Published in Br J Clin Pharmacol on July 01, 1988
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J (1992) 1.44
An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br J Clin Pharmacol (1988) 1.29
Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol (1992) 1.13
Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues. Br J Clin Pharmacol (1990) 0.87
Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes. Br J Clin Pharmacol (1999) 0.82
Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites. Br J Clin Pharmacol (1990) 0.76
A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro. Br J Clin Pharmacol (1989) 0.76
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts. Br J Clin Pharmacol (1989) 0.75
The immunological basis of adverse drug reactions. A report on a symposium held in Liverpool on 6th April 1988. Br J Clin Pharmacol (1988) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem (1964) 24.57
Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. Cancer Res (1970) 4.83
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89
An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Pharmacol Exp Ther (1978) 2.40
Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol (1980) 1.69
The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol (1987) 1.63
Penicillin allergy and the heterogenous immune responses of man to benzylpenicillin. J Clin Invest (1966) 1.54
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
Drug disposition and drug hypersensitivity. Biochem Pharmacol (1987) 1.46
Progress in hepatology. Metabolic activation of drugs to toxic substances. Gastroenterology (1975) 1.42
Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. Science (1982) 1.41
Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung. Nature (1977) 1.41
Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med (1981) 1.29
Thrombocytopenia and leucopenia with mianserin-dependent antibodies. Br J Clin Pharmacol (1985) 1.25
Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. J Med Chem (1982) 1.07
Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med (1986) 1.07
Activation mechanisms to chemical toxicity. Arch Toxicol (1987) 1.05
The biliary and urinary metabolites of [3H]17 alpha-ethynylestradiol in women. Xenobiotica (1983) 0.97
The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen. Drug Metab Dispos (1985) 0.94
Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis. Am J Reprod Immunol (1982) 0.93
Pharmacological inhibition of aldose reductase in human diabetic neuropathy. Drugs (1986) 0.92
Carcinogens, drugs, and cytochromes P-450. N Engl J Med (1983) 0.91
Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man. Drug Metab Dispos (1983) 0.89
Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. Biochem Pharmacol (1988) 0.88
The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites. Drug Metab Dispos (1981) 0.87
Drug-protein conjugates--XVI. Studies of sorbinil metabolism: formation of 2-hydroxysorbinil and unstable protein conjugates. Biochem Pharmacol (1988) 0.82
Positive skin reaction induced by 4,4'-azoxybenzenedisulfonamide in relationship to the sulfanilamide allergy. Int Arch Allergy Appl Immunol (1977) 0.78
Metabolic activation of the tricyclic antidepressant amineptine by human liver cytochrome P-450. Biochem Pharmacol (1987) 0.78
Drug-protein conjugates--II. An investigation of the irreversible binding and metabolism of 17 alpha-ethinyl estradiol in vivo. Biochem Pharmacol (1983) 0.78
Metabolic disposition and irreversible binding of phencyclidine in rats. Toxicol Appl Pharmacol (1981) 0.78
Metabolic activation of the tricyclic antidepressant amineptine--II. Protective role of glutathione against in vitro and in vivo covalent binding. Biochem Pharmacol (1987) 0.77
Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol (1979) 3.32
Adverse drug reactions. BMJ (1998) 3.25
A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is the site of cross-regulatory interactions between Dlx genes in the embryonic forebrain. J Neurosci (2000) 2.98
Response by women aged 65-79 to invitation for screening for breast cancer by mammography: a pilot study. BMJ (1990) 2.51
Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokinet (1981) 2.25
The Old English Medical Vocabulary: (Section of the History of Medicine). Proc R Soc Med (1940) 2.09
The problem of college drinking: insights from a developmental perspective. Alcohol Clin Exp Res (2001) 2.01
4-Aminoquinolines--past, present, and future: a chemical perspective. Pharmacol Ther (1998) 2.00
A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine. J Steroid Biochem (1978) 1.90
Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J (2006) 1.87
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol (2004) 1.77
Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol (1992) 1.68
The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol (1987) 1.63
Differential detection of transmissible gastroenteritis virus and porcine epidemic diarrhea virus by duplex RT-PCR. J Vet Diagn Invest (2001) 1.59
Roseobacter gallaeciensis sp. nov., a new marine bacterium isolated from rearings and collectors of the scallop Pecten maximus. Int J Syst Bacteriol (1998) 1.57
An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol (1990) 1.53
Phylogenetic analysis of swine influenza viruses recently isolated in Korea. Virus Genes (2008) 1.52
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52
Assessment of the drug metabolism capacity of the liver. Br J Clin Pharmacol (1982) 1.51
Differentiation of a Vero cell adapted porcine epidemic diarrhea virus from Korean field strains by restriction fragment length polymorphism analysis of ORF 3. Vaccine (2003) 1.47
Drug disposition and drug hypersensitivity. Biochem Pharmacol (1987) 1.46
A study of the effect of anticoagulants on [3H]vitamin K1 metabolism and prothrombin complex activity in the rabbit. Biochem Pharmacol (1979) 1.46
Isolation and phylogenetic analysis of H1N1 swine influenza virus isolated in Korea. Virus Res (2006) 1.45
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines. Br J Clin Pharmacol (1988) 1.44
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J (1992) 1.44
Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci (2001) 1.43
Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time. J Am Coll Cardiol (1990) 1.40
Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci U S A (2000) 1.40
Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice. Infect Immun (2003) 1.38
Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol (2003) 1.35
4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J Biol Chem (1996) 1.35
The burden of alcohol misuse on an inner-city general hospital. QJM (2000) 1.31
An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br J Clin Pharmacol (1988) 1.29
High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis (1999) 1.28
Application of scanning electron microscopy in assessing the prevalence of some Setaria species in Korean cattle. Korean J Parasitol (1994) 1.27
Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol (1989) 1.27
Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity. Br J Clin Pharmacol (1981) 1.26
The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction. Br J Clin Pharmacol (1986) 1.26
Plasma disposition of vitamin K1 in relation to anticoagulant poisoning. Br J Clin Pharmacol (1984) 1.26
The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol (1991) 1.25
Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A (1997) 1.25
Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. Lancet (2005) 1.24
Emerging standards for diabetes care from a city-wide primary care audit. Diabet Med (1994) 1.24
Use of laser microdissection greatly improves the recovery of DNA from sperm on microscope slides. Forensic Sci Int (2003) 1.23
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. J Clin Microbiol (2001) 1.22
Cimetidine potentiates the anticoagulant effect of warfarin by inhibition of drug metabolism. Biochem Pharmacol (1980) 1.21
Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs. Br J Clin Pharmacol (1984) 1.19
Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element. J Virol (1995) 1.19
Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med (2000) 1.19
Effects of cimetidine on carbamazepine auto- and hetero-induction in man. Br J Clin Pharmacol (1984) 1.19
Uptake of glutamate in Corynebacterium glutamicum. 1. Kinetic properties and regulation by internal pH and potassium. Eur J Biochem (1990) 1.18
One-step multiplex RT-PCR for detection and subtyping of swine influenza H1, H3, N1, N2 viruses in clinical samples using a dual priming oligonucleotide (DPO) system. J Virol Methods (2008) 1.18
Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine. Br J Clin Pharmacol (1983) 1.17
Measurement of cortisol metabolites in faeces of ruminants. Vet Res Commun (2002) 1.16
Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol Biochem Parasitol (1996) 1.15
Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol (2000) 1.13
Effect of chloroquine and primaquine on antipyrine metabolism. Br J Clin Pharmacol (1983) 1.13
Problems of anticoagulation with warfarin in hyperthyroidism. Q J Med (1986) 1.12
Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int (2001) 1.11
Interspecies transmission of the canine influenza H3N2 virus to domestic cats in South Korea, 2010. J Gen Virol (2011) 1.10
A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit. Biochem Pharmacol (1982) 1.10
Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther (1982) 1.10
The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette. Contraception (1981) 1.09
Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Br J Pharmacol (1998) 1.09
Uptake of glutamate in Corynebacterium glutamicum. 2. Evidence for a primary active transport system. Eur J Biochem (1990) 1.09
Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]. Br J Clin Pharmacol (1978) 1.09
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br J Clin Pharmacol (1988) 1.07
Preventive dental behavior of urban mothers. J Health Hum Behav (1965) 1.07
The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. Clin Pharmacol Ther (2012) 1.06
Difenacoum (Neosorexa) poisoning. Br Med J (Clin Res Ed) (1982) 1.06
Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. J Pharmacol Exp Ther (1996) 1.06
The effect of enzyme induction on diazepam metabolism in man. Br J Clin Pharmacol (1979) 1.05
Serum cytokine changes in systemic vasculitis. Immunology (1989) 1.05
Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects. Br J Clin Pharmacol (1981) 1.05
Carbamazepine is not a substrate for P-glycoprotein. Br J Clin Pharmacol (2001) 1.05
Adaptations to swimming training: influence of training volume. Med Sci Sports Exerc (1991) 1.04
Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. J Antimicrob Chemother (1991) 1.04
A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit. Br J Pharmacol (1985) 1.04
Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br J Clin Pharmacol (1986) 1.04
[Isolation and identification of Cryptosporidium from various animals in Korea. I. Prevalence of Cryptosporidium in various animals]. Kisaengchunghak Chapchi (1991) 1.04
Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf (2000) 1.03
Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis Cartilage (2010) 1.03
Plasma vitamin K1 concentrations in cystic fibrosis. Arch Dis Child (1989) 1.02
TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology (2001) 1.02
Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol (2010) 1.02
Interaction between warfarin and propranolol. Br J Clin Pharmacol (1984) 1.01
Efflux of compatible solutes in Corynebacterium glutamicum mediated by osmoregulated channel activity. Eur J Biochem (1997) 1.01
Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model. Br J Pharmacol (2008) 1.01
Quantitative analysis of pharmacological levels of vitamin K1 and vitamin K1 2,3-epoxide in rabbit plasma by high-performance liquid chromatography. J Chromatogr (1983) 1.01
The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide. Drug Metab Dispos (1997) 1.01
S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br J Cancer (2009) 1.01
Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res (2009) 1.00
Sleep and circadian phase characteristics of adolescent and young adult males in a naturalistic summertime condition. Chronobiol Int (2000) 1.00